27 May 2026 : Clinical Research
Long-Term Durability and Dynamics of Anti-S-RBD IgG Response in Healthcare Workers: A Comparative Analysis of Homologous and Heterologous SARS-CoV-2 Vaccination Schedules in a 1-Year Serial Cross-Sectional Study
Çiğdem DemirelDOI: 10.12659/MSM.952930
Med Sci Monit 2026; 32:e952930
Table 3 Distribution of anti-S-RBD IgG according to vaccine status and vaccination type.
| Vaccination group | n | Median (AU/mL) | 95% CI |
|---|---|---|---|
| SSS | 39 | 77.5 | 70.1–84.9 |
| BBB | 67 | 124.5 | 118.2–130.8 |
| SSB | 60 | 105.6 | 99.1–112.1 |
| SSBB | 90 | 112.3 | 106.0–118.6 |
| SSBBB | 51 | 110.1 | 101.9–118.3 |
| Homologous | 106 | 103.9 | 98.2–109.1 |
| Heterologous | 201 | 109.1 | 104.5–113.8 |






